• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Leadership

The Treasury Will Crack Down on ‘Tax Inversions’ This Week

By
Geoffrey Smith
Geoffrey Smith
Down Arrow Button Icon
By
Geoffrey Smith
Geoffrey Smith
Down Arrow Button Icon
November 19, 2015, 4:31 AM ET
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
CANONSBURG, PA - JULY 14: The Interior of Mylan headquarters is seen July 14, 2014 in Canonsburg, Pennsylvania The generic drugmaker Mylan is buying Abbott Laboratories' generic-drugs business in developed markets for stock valued at about $5.3 billion. (Photo by Jeff Swensen/Getty Images)Photograph by Jeff Swensen — Getty Images

The U.S. Treasury department is set to unveil its latest plans to crack down on corporations who cut their tax bills by moving their domicile abroad.

According to The Wall Street Journal, Treasury will publish “targeted guidance” later this week on how to limit the tax benefits of such moves. It cited a letter to lawmakers by Treasury Secretary Jack Lew.

The Obama administration has been gunning for so called ‘inversions’, in which a U.S. company buys a smaller foreign company and then locates the merged company outside the U.S. for tax purposes, for over a year, but that hasn’t stopped the flow of deals. It still hasn’t issued the formal regulations it promised last year.

“Treasury cannot stop inversions without new statutory authority,” Lew wrote. “Unless and until Congress acts, creative accountants and lawyers will continue to find new ways for companies to move their tax residences overseas and avoid paying taxes here at home.”

The trend to inversions has been particularly strong in the pharmaceuticals sector, where many essentially U.S.-based or -focused companies have shifted their tax domicile to countries such as Ireland or the Netherlands, which have particularly generous corporate tax regimes, especially as regards monetizing patent-protected intellectual property. Last month, it emerged that Pfizer Inc. (PFE) had approached Ireland-domiciled Allergan Plc (AGN) over just such a deal.

“By relocating their tax residences overseas, inverted companies erode the U.S. income tax base and place a greater financial burden on other businesses and American families,” Lew wrote.

Treasury has warned that any new regulations could be retroactive to September 2014. That means that they could affect companies such as medical goods maker Medtronic Plc (MDT), which inverted after buying rival Covidian last year, and pharma company Mylan NV, (MYL) which did the same after buying Abbott Laboratories.

For more on how the corporate sector views inversions, watch Mylan CEO Heather Bresch defend the practise last month at Fortune’s Most Powerful Women summit last month (and read more here).

About the Author
By Geoffrey Smith
See full bioRight Arrow Button Icon

Latest in Leadership

Nicholas Thompson
C-SuiteBook Excerpt
I took over one of the most prestigious media firms while training for an ultramarathon. Here’s what I learned becoming CEO of The Atlantic
By Nicholas ThompsonDecember 13, 2025
13 hours ago
Lauren Antonoff
SuccessCareers
Once a college dropout, this CEO went back to school at 52—but she still says the Gen Zers who will succeed are those who ‘forge their own path’
By Preston ForeDecember 13, 2025
14 hours ago
Asiathe future of work
The CEO of one of Asia’s largest co-working space providers says his business has more in common with hotels
By Angelica AngDecember 12, 2025
22 hours ago
Donald Trump
HealthHealth Insurance
‘Tragedy in the making’: Top healthcare exec on why insurance will spike to subsidize a tax cut to millionaires and billionaires
By Nick LichtenbergDecember 12, 2025
1 day ago
three men in suits, one gesturing
AIBrainstorm AI
The fastest athletes in the world can botch a baton pass if trust isn’t there—and the same is true of AI, Blackbaud exec says
By Amanda GerutDecember 12, 2025
1 day ago
Brainstorm AI panel
AIBrainstorm AI
Creative workers won’t be replaced by AI—but their roles will change to become ‘directors’ managing AI agents, executives say
By Beatrice NolanDecember 12, 2025
1 day ago

Most Popular

placeholder alt text
Economy
Tariffs are taxes and they were used to finance the federal government until the 1913 income tax. A top economist breaks it down
By Kent JonesDecember 12, 2025
2 days ago
placeholder alt text
Success
Apple cofounder Ronald Wayne sold his 10% stake for $800 in 1976—today it’d be worth up to $400 billion
By Preston ForeDecember 12, 2025
1 day ago
placeholder alt text
Success
40% of Stanford undergrads receive disability accommodations—but it’s become a college-wide phenomenon as Gen Z try to succeed in the current climate
By Preston ForeDecember 12, 2025
1 day ago
placeholder alt text
Economy
The Fed just ‘Trump-proofed’ itself with a unanimous move to preempt a potential leadership shake-up
By Jason MaDecember 12, 2025
1 day ago
placeholder alt text
Economy
For the first time since Trump’s tariff rollout, import tax revenue has fallen, threatening his lofty plans to slash the $38 trillion national debt
By Sasha RogelbergDecember 12, 2025
1 day ago
placeholder alt text
Success
Apple CEO Tim Cook out-earns the average American’s salary in just 7 hours—to put that into context, he could buy a new $439,000 home in just 2 days
By Emma BurleighDecember 12, 2025
1 day ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.